0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Congenital Heart Disease Treatment Device Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-1K10243
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Congenital Heart Disease Treatment Device Market Insights Forecast to 2028
BUY CHAPTERS

Global Congenital Heart Disease Treatment Device Market Research Report 2025

Code: QYRE-Auto-1K10243
Report
July 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Congenital Heart Disease Treatment Device Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Congenital Heart Disease Treatment Device Market

Congenital Heart Disease Treatment Device Market

The global market for Congenital Heart Disease Treatment Device was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Congenital heart disease (CHD) is a cardiovascular malformation caused by abnormal fetal heart and blood vessel development, and it is one of the most common congenital malformations.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Congenital Heart Disease Treatment Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Congenital Heart Disease Treatment Device.
The Congenital Heart Disease Treatment Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Congenital Heart Disease Treatment Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Congenital Heart Disease Treatment Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Congenital Heart Disease Treatment Device Market Report

Report Metric Details
Report Name Congenital Heart Disease Treatment Device Market
CAGR 5%
Segment by Type
Segment by Application
  • Adult
  • Children
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott, Medtronic plc, Beijing Balance Medical Technology, Med-Zenith, MicroPort, Weigao Holding Company Limited, CryoLife, Edwards LifeSciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Congenital Heart Disease Treatment Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Congenital Heart Disease Treatment Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Congenital Heart Disease Treatment Device Market report?

Ans: The main players in the Congenital Heart Disease Treatment Device Market are Abbott, Medtronic plc, Beijing Balance Medical Technology, Med-Zenith, MicroPort, Weigao Holding Company Limited, CryoLife, Edwards LifeSciences

What are the Application segmentation covered in the Congenital Heart Disease Treatment Device Market report?

Ans: The Applications covered in the Congenital Heart Disease Treatment Device Market report are Adult, Children

What are the Type segmentation covered in the Congenital Heart Disease Treatment Device Market report?

Ans: The Types covered in the Congenital Heart Disease Treatment Device Market report are Artificial Heart Valve, Bracket, Ventricular Assist Device (VAD), Other

Recommended Reports

Cardiac Devices

Cardiovascular Therapies

Cardiovascular Diagnostics

1 Congenital Heart Disease Treatment Device Market Overview
1.1 Product Definition
1.2 Congenital Heart Disease Treatment Device by Type
1.2.1 Global Congenital Heart Disease Treatment Device Market Value Comparison by Type (2024 VS 2031)
1.2.2 Artificial Heart Valve
1.2.3 Bracket
1.2.4 Ventricular Assist Device (VAD)
1.2.5 Other
1.3 Congenital Heart Disease Treatment Device by Application
1.3.1 Global Congenital Heart Disease Treatment Device Market Value by Application (2024 VS 2031)
1.3.2 Adult
1.3.3 Children
1.4 Global Congenital Heart Disease Treatment Device Market Size Estimates and Forecasts
1.4.1 Global Congenital Heart Disease Treatment Device Revenue 2020-2031
1.4.2 Global Congenital Heart Disease Treatment Device Sales 2020-2031
1.4.3 Global Congenital Heart Disease Treatment Device Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Congenital Heart Disease Treatment Device Market Competition by Manufacturers
2.1 Global Congenital Heart Disease Treatment Device Sales Market Share by Manufacturers (2020-2025)
2.2 Global Congenital Heart Disease Treatment Device Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Congenital Heart Disease Treatment Device Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Congenital Heart Disease Treatment Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Congenital Heart Disease Treatment Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Congenital Heart Disease Treatment Device, Product Type & Application
2.7 Global Key Manufacturers of Congenital Heart Disease Treatment Device, Date of Enter into This Industry
2.8 Global Congenital Heart Disease Treatment Device Market Competitive Situation and Trends
2.8.1 Global Congenital Heart Disease Treatment Device Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Congenital Heart Disease Treatment Device Players Market Share by Revenue
2.8.3 Global Congenital Heart Disease Treatment Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Congenital Heart Disease Treatment Device Market Scenario by Region
3.1 Global Congenital Heart Disease Treatment Device Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Congenital Heart Disease Treatment Device Sales by Region: 2020-2031
3.2.1 Global Congenital Heart Disease Treatment Device Sales by Region: 2020-2025
3.2.2 Global Congenital Heart Disease Treatment Device Sales by Region: 2026-2031
3.3 Global Congenital Heart Disease Treatment Device Revenue by Region: 2020-2031
3.3.1 Global Congenital Heart Disease Treatment Device Revenue by Region: 2020-2025
3.3.2 Global Congenital Heart Disease Treatment Device Revenue by Region: 2026-2031
3.4 North America Congenital Heart Disease Treatment Device Market Facts & Figures by Country
3.4.1 North America Congenital Heart Disease Treatment Device Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Congenital Heart Disease Treatment Device Sales by Country (2020-2031)
3.4.3 North America Congenital Heart Disease Treatment Device Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Congenital Heart Disease Treatment Device Market Facts & Figures by Country
3.5.1 Europe Congenital Heart Disease Treatment Device Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Congenital Heart Disease Treatment Device Sales by Country (2020-2031)
3.5.3 Europe Congenital Heart Disease Treatment Device Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Congenital Heart Disease Treatment Device Market Facts & Figures by Region
3.6.1 Asia Pacific Congenital Heart Disease Treatment Device Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Congenital Heart Disease Treatment Device Sales by Region (2020-2031)
3.6.3 Asia Pacific Congenital Heart Disease Treatment Device Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Congenital Heart Disease Treatment Device Market Facts & Figures by Country
3.7.1 Latin America Congenital Heart Disease Treatment Device Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Congenital Heart Disease Treatment Device Sales by Country (2020-2031)
3.7.3 Latin America Congenital Heart Disease Treatment Device Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Congenital Heart Disease Treatment Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Congenital Heart Disease Treatment Device Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Congenital Heart Disease Treatment Device Sales by Country (2020-2031)
3.8.3 Middle East and Africa Congenital Heart Disease Treatment Device Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Congenital Heart Disease Treatment Device Sales by Type (2020-2031)
4.1.1 Global Congenital Heart Disease Treatment Device Sales by Type (2020-2025)
4.1.2 Global Congenital Heart Disease Treatment Device Sales by Type (2026-2031)
4.1.3 Global Congenital Heart Disease Treatment Device Sales Market Share by Type (2020-2031)
4.2 Global Congenital Heart Disease Treatment Device Revenue by Type (2020-2031)
4.2.1 Global Congenital Heart Disease Treatment Device Revenue by Type (2020-2025)
4.2.2 Global Congenital Heart Disease Treatment Device Revenue by Type (2026-2031)
4.2.3 Global Congenital Heart Disease Treatment Device Revenue Market Share by Type (2020-2031)
4.3 Global Congenital Heart Disease Treatment Device Price by Type (2020-2031)
5 Segment by Application
5.1 Global Congenital Heart Disease Treatment Device Sales by Application (2020-2031)
5.1.1 Global Congenital Heart Disease Treatment Device Sales by Application (2020-2025)
5.1.2 Global Congenital Heart Disease Treatment Device Sales by Application (2026-2031)
5.1.3 Global Congenital Heart Disease Treatment Device Sales Market Share by Application (2020-2031)
5.2 Global Congenital Heart Disease Treatment Device Revenue by Application (2020-2031)
5.2.1 Global Congenital Heart Disease Treatment Device Revenue by Application (2020-2025)
5.2.2 Global Congenital Heart Disease Treatment Device Revenue by Application (2026-2031)
5.2.3 Global Congenital Heart Disease Treatment Device Revenue Market Share by Application (2020-2031)
5.3 Global Congenital Heart Disease Treatment Device Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Congenital Heart Disease Treatment Device Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott Congenital Heart Disease Treatment Device Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Medtronic plc
6.2.1 Medtronic plc Company Information
6.2.2 Medtronic plc Description and Business Overview
6.2.3 Medtronic plc Congenital Heart Disease Treatment Device Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Medtronic plc Congenital Heart Disease Treatment Device Product Portfolio
6.2.5 Medtronic plc Recent Developments/Updates
6.3 Beijing Balance Medical Technology
6.3.1 Beijing Balance Medical Technology Company Information
6.3.2 Beijing Balance Medical Technology Description and Business Overview
6.3.3 Beijing Balance Medical Technology Congenital Heart Disease Treatment Device Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Beijing Balance Medical Technology Congenital Heart Disease Treatment Device Product Portfolio
6.3.5 Beijing Balance Medical Technology Recent Developments/Updates
6.4 Med-Zenith
6.4.1 Med-Zenith Company Information
6.4.2 Med-Zenith Description and Business Overview
6.4.3 Med-Zenith Congenital Heart Disease Treatment Device Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Med-Zenith Congenital Heart Disease Treatment Device Product Portfolio
6.4.5 Med-Zenith Recent Developments/Updates
6.5 MicroPort
6.5.1 MicroPort Company Information
6.5.2 MicroPort Description and Business Overview
6.5.3 MicroPort Congenital Heart Disease Treatment Device Sales, Revenue and Gross Margin (2020-2025)
6.5.4 MicroPort Congenital Heart Disease Treatment Device Product Portfolio
6.5.5 MicroPort Recent Developments/Updates
6.6 Weigao Holding Company Limited
6.6.1 Weigao Holding Company Limited Company Information
6.6.2 Weigao Holding Company Limited Description and Business Overview
6.6.3 Weigao Holding Company Limited Congenital Heart Disease Treatment Device Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Weigao Holding Company Limited Congenital Heart Disease Treatment Device Product Portfolio
6.6.5 Weigao Holding Company Limited Recent Developments/Updates
6.7 CryoLife
6.7.1 CryoLife Company Information
6.7.2 CryoLife Description and Business Overview
6.7.3 CryoLife Congenital Heart Disease Treatment Device Sales, Revenue and Gross Margin (2020-2025)
6.7.4 CryoLife Congenital Heart Disease Treatment Device Product Portfolio
6.7.5 CryoLife Recent Developments/Updates
6.8 Edwards LifeSciences
6.8.1 Edwards LifeSciences Company Information
6.8.2 Edwards LifeSciences Description and Business Overview
6.8.3 Edwards LifeSciences Congenital Heart Disease Treatment Device Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Edwards LifeSciences Congenital Heart Disease Treatment Device Product Portfolio
6.8.5 Edwards LifeSciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Congenital Heart Disease Treatment Device Industry Chain Analysis
7.2 Congenital Heart Disease Treatment Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Congenital Heart Disease Treatment Device Production Mode & Process Analysis
7.4 Congenital Heart Disease Treatment Device Sales and Marketing
7.4.1 Congenital Heart Disease Treatment Device Sales Channels
7.4.2 Congenital Heart Disease Treatment Device Distributors
7.5 Congenital Heart Disease Treatment Device Customer Analysis
8 Congenital Heart Disease Treatment Device Market Dynamics
8.1 Congenital Heart Disease Treatment Device Industry Trends
8.2 Congenital Heart Disease Treatment Device Market Drivers
8.3 Congenital Heart Disease Treatment Device Market Challenges
8.4 Congenital Heart Disease Treatment Device Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Congenital Heart Disease Treatment Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Congenital Heart Disease Treatment Device Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Congenital Heart Disease Treatment Device Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Congenital Heart Disease Treatment Device Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Congenital Heart Disease Treatment Device Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Congenital Heart Disease Treatment Device Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Congenital Heart Disease Treatment Device Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Congenital Heart Disease Treatment Device Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Congenital Heart Disease Treatment Device, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Congenital Heart Disease Treatment Device, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Congenital Heart Disease Treatment Device, Product Type & Application
 Table 12. Global Key Manufacturers of Congenital Heart Disease Treatment Device, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Congenital Heart Disease Treatment Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Congenital Heart Disease Treatment Device as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Congenital Heart Disease Treatment Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Congenital Heart Disease Treatment Device Sales by Region (2020-2025) & (K Units)
 Table 18. Global Congenital Heart Disease Treatment Device Sales Market Share by Region (2020-2025)
 Table 19. Global Congenital Heart Disease Treatment Device Sales by Region (2026-2031) & (K Units)
 Table 20. Global Congenital Heart Disease Treatment Device Sales Market Share by Region (2026-2031)
 Table 21. Global Congenital Heart Disease Treatment Device Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Congenital Heart Disease Treatment Device Revenue Market Share by Region (2020-2025)
 Table 23. Global Congenital Heart Disease Treatment Device Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Congenital Heart Disease Treatment Device Revenue Market Share by Region (2026-2031)
 Table 25. North America Congenital Heart Disease Treatment Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Congenital Heart Disease Treatment Device Sales by Country (2020-2025) & (K Units)
 Table 27. North America Congenital Heart Disease Treatment Device Sales by Country (2026-2031) & (K Units)
 Table 28. North America Congenital Heart Disease Treatment Device Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Congenital Heart Disease Treatment Device Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Congenital Heart Disease Treatment Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Congenital Heart Disease Treatment Device Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Congenital Heart Disease Treatment Device Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Congenital Heart Disease Treatment Device Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Congenital Heart Disease Treatment Device Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Congenital Heart Disease Treatment Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Congenital Heart Disease Treatment Device Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Congenital Heart Disease Treatment Device Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Congenital Heart Disease Treatment Device Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Congenital Heart Disease Treatment Device Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Congenital Heart Disease Treatment Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Congenital Heart Disease Treatment Device Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Congenital Heart Disease Treatment Device Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Congenital Heart Disease Treatment Device Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Congenital Heart Disease Treatment Device Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Congenital Heart Disease Treatment Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Congenital Heart Disease Treatment Device Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Congenital Heart Disease Treatment Device Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Congenital Heart Disease Treatment Device Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Congenital Heart Disease Treatment Device Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Congenital Heart Disease Treatment Device Sales (K Units) by Type (2020-2025)
 Table 51. Global Congenital Heart Disease Treatment Device Sales (K Units) by Type (2026-2031)
 Table 52. Global Congenital Heart Disease Treatment Device Sales Market Share by Type (2020-2025)
 Table 53. Global Congenital Heart Disease Treatment Device Sales Market Share by Type (2026-2031)
 Table 54. Global Congenital Heart Disease Treatment Device Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Congenital Heart Disease Treatment Device Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Congenital Heart Disease Treatment Device Revenue Market Share by Type (2020-2025)
 Table 57. Global Congenital Heart Disease Treatment Device Revenue Market Share by Type (2026-2031)
 Table 58. Global Congenital Heart Disease Treatment Device Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Congenital Heart Disease Treatment Device Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Congenital Heart Disease Treatment Device Sales (K Units) by Application (2020-2025)
 Table 61. Global Congenital Heart Disease Treatment Device Sales (K Units) by Application (2026-2031)
 Table 62. Global Congenital Heart Disease Treatment Device Sales Market Share by Application (2020-2025)
 Table 63. Global Congenital Heart Disease Treatment Device Sales Market Share by Application (2026-2031)
 Table 64. Global Congenital Heart Disease Treatment Device Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Congenital Heart Disease Treatment Device Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Congenital Heart Disease Treatment Device Revenue Market Share by Application (2020-2025)
 Table 67. Global Congenital Heart Disease Treatment Device Revenue Market Share by Application (2026-2031)
 Table 68. Global Congenital Heart Disease Treatment Device Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Congenital Heart Disease Treatment Device Price (US$/Unit) by Application (2026-2031)
 Table 70. Abbott Company Information
 Table 71. Abbott Description and Business Overview
 Table 72. Abbott Congenital Heart Disease Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Abbott Congenital Heart Disease Treatment Device Product
 Table 74. Abbott Recent Developments/Updates
 Table 75. Medtronic plc Company Information
 Table 76. Medtronic plc Description and Business Overview
 Table 77. Medtronic plc Congenital Heart Disease Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Medtronic plc Congenital Heart Disease Treatment Device Product
 Table 79. Medtronic plc Recent Developments/Updates
 Table 80. Beijing Balance Medical Technology Company Information
 Table 81. Beijing Balance Medical Technology Description and Business Overview
 Table 82. Beijing Balance Medical Technology Congenital Heart Disease Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Beijing Balance Medical Technology Congenital Heart Disease Treatment Device Product
 Table 84. Beijing Balance Medical Technology Recent Developments/Updates
 Table 85. Med-Zenith Company Information
 Table 86. Med-Zenith Description and Business Overview
 Table 87. Med-Zenith Congenital Heart Disease Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Med-Zenith Congenital Heart Disease Treatment Device Product
 Table 89. Med-Zenith Recent Developments/Updates
 Table 90. MicroPort Company Information
 Table 91. MicroPort Description and Business Overview
 Table 92. MicroPort Congenital Heart Disease Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. MicroPort Congenital Heart Disease Treatment Device Product
 Table 94. MicroPort Recent Developments/Updates
 Table 95. Weigao Holding Company Limited Company Information
 Table 96. Weigao Holding Company Limited Description and Business Overview
 Table 97. Weigao Holding Company Limited Congenital Heart Disease Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Weigao Holding Company Limited Congenital Heart Disease Treatment Device Product
 Table 99. Weigao Holding Company Limited Recent Developments/Updates
 Table 100. CryoLife Company Information
 Table 101. CryoLife Description and Business Overview
 Table 102. CryoLife Congenital Heart Disease Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. CryoLife Congenital Heart Disease Treatment Device Product
 Table 104. CryoLife Recent Developments/Updates
 Table 105. Edwards LifeSciences Company Information
 Table 106. Edwards LifeSciences Description and Business Overview
 Table 107. Edwards LifeSciences Congenital Heart Disease Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Edwards LifeSciences Congenital Heart Disease Treatment Device Product
 Table 109. Edwards LifeSciences Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Congenital Heart Disease Treatment Device Distributors List
 Table 113. Congenital Heart Disease Treatment Device Customers List
 Table 114. Congenital Heart Disease Treatment Device Market Trends
 Table 115. Congenital Heart Disease Treatment Device Market Drivers
 Table 116. Congenital Heart Disease Treatment Device Market Challenges
 Table 117. Congenital Heart Disease Treatment Device Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Congenital Heart Disease Treatment Device
 Figure 2. Global Congenital Heart Disease Treatment Device Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Congenital Heart Disease Treatment Device Market Share by Type: 2024 & 2031
 Figure 4. Artificial Heart Valve Product Picture
 Figure 5. Bracket Product Picture
 Figure 6. Ventricular Assist Device (VAD) Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Congenital Heart Disease Treatment Device Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Congenital Heart Disease Treatment Device Market Share by Application: 2024 & 2031
 Figure 10. Adult
 Figure 11. Children
 Figure 12. Global Congenital Heart Disease Treatment Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Congenital Heart Disease Treatment Device Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Congenital Heart Disease Treatment Device Sales (2020-2031) & (K Units)
 Figure 15. Global Congenital Heart Disease Treatment Device Average Price (US$/Unit) & (2020-2031)
 Figure 16. Congenital Heart Disease Treatment Device Report Years Considered
 Figure 17. Congenital Heart Disease Treatment Device Sales Share by Manufacturers in 2024
 Figure 18. Global Congenital Heart Disease Treatment Device Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Congenital Heart Disease Treatment Device Players: Market Share by Revenue in Congenital Heart Disease Treatment Device in 2024
 Figure 20. Congenital Heart Disease Treatment Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Congenital Heart Disease Treatment Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Congenital Heart Disease Treatment Device Sales Market Share by Country (2020-2031)
 Figure 23. North America Congenital Heart Disease Treatment Device Revenue Market Share by Country (2020-2031)
 Figure 24. United States Congenital Heart Disease Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Congenital Heart Disease Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Congenital Heart Disease Treatment Device Sales Market Share by Country (2020-2031)
 Figure 27. Europe Congenital Heart Disease Treatment Device Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Congenital Heart Disease Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Congenital Heart Disease Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Congenital Heart Disease Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Congenital Heart Disease Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Congenital Heart Disease Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Congenital Heart Disease Treatment Device Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Congenital Heart Disease Treatment Device Revenue Market Share by Region (2020-2031)
 Figure 35. China Congenital Heart Disease Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Congenital Heart Disease Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Congenital Heart Disease Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Congenital Heart Disease Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Congenital Heart Disease Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Congenital Heart Disease Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Congenital Heart Disease Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Congenital Heart Disease Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Congenital Heart Disease Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Congenital Heart Disease Treatment Device Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Congenital Heart Disease Treatment Device Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Congenital Heart Disease Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Congenital Heart Disease Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Congenital Heart Disease Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Congenital Heart Disease Treatment Device Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Congenital Heart Disease Treatment Device Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Congenital Heart Disease Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Congenital Heart Disease Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Congenital Heart Disease Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Congenital Heart Disease Treatment Device by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Congenital Heart Disease Treatment Device by Type (2020-2031)
 Figure 56. Global Congenital Heart Disease Treatment Device Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Congenital Heart Disease Treatment Device by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Congenital Heart Disease Treatment Device by Application (2020-2031)
 Figure 59. Global Congenital Heart Disease Treatment Device Price (US$/Unit) by Application (2020-2031)
 Figure 60. Congenital Heart Disease Treatment Device Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart